Clinical Trials · NCT07663318

A Phase 1 Study to Evaluate the Relative Bioavailability of Octreotide Acetate Tablets(T25) Compared to MYCAPSSA® and The Food Effect on Pharmacokinetics Of Octreotide Acetate Tablets(T25)

Name: A Phase 1 Study to Evaluate the Relative Bioavailability of Octreotide Acetate Tablets(T25) Compared to MYCAPSSA® and The Food Effect on Pharmacokinetics Of Octreotide Acetate Tablets(T25)
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

CompletedPhase 1Octreotide

Phase: Phase 1
Recruitment status: Completed
Sponsor: Triastek (Shanghai) Limited
Enrollment: 18
Start date: Jun 2026
Locations: 1 site, China
Primary endpoint: bioavailability

View Octreotide compound reference